LUNAR

Pivotal, randomized, open-label study of Tumor Treating Fields concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure

Study Name:
LUNAR: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard of care therapies for treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure.

Targeted Disease(s):
Lung Cancer

Purpose of Study:

To test the efficacy and safety of TTFields, using the NovoTTF-100L system, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment.

 

Study Dates:
December 1, 2016 - September 30, 2023

Study Location:
FL

Lead Institution:
BRCR medical center

Funding Source:
Novocure

ClinicalTrails.gov Identifier:
NCT02973789

Contact:
Victoria Reyes
Contact Phone: 561-447-0614
Contact Email: vreyes@brcrglobal.com

Freedom From Smoking Clinic
, | Oct 25, 2021
Community Connections: Air Quality & Lung Disease
, | Jan 19, 2022